Aptorum Group Ltd Stock Performance
| APM Stock | USD 2.14 0.06 2.73% |
Aptorum Group holds a performance score of 6 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -2.06, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Aptorum Group are expected to decrease by larger amounts. On the other hand, during market turmoil, Aptorum Group is expected to outperform it. Use Aptorum Group semi variance, and the relationship between the maximum drawdown and accumulation distribution , to analyze future returns on Aptorum Group.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Aptorum Group Ltd are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Aptorum Group displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 5 M |
Aptorum |
Aptorum Group Relative Risk vs. Return Landscape
If you would invest 177.00 in Aptorum Group Ltd on October 6, 2024 and sell it today you would earn a total of 37.00 from holding Aptorum Group Ltd or generate 20.9% return on investment over 90 days. Aptorum Group Ltd is generating 1.4267% of daily returns assuming volatility of 17.2331% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than Aptorum, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Aptorum Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aptorum Group's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aptorum Group Ltd, and traders can use it to determine the average amount a Aptorum Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0828
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | APM | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 17.23 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.43 actual daily | 28 72% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Aptorum Group is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aptorum Group by adding it to a well-diversified portfolio.
Aptorum Group Fundamentals Growth
Aptorum Stock prices reflect investors' perceptions of the future prospects and financial health of Aptorum Group, and Aptorum Group fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aptorum Stock performance.
| Return On Equity | -0.37 | ||||
| Return On Asset | -0.32 | ||||
| Operating Margin | (24.86) % | ||||
| Current Valuation | 14.86 M | ||||
| Shares Outstanding | 3.81 M | ||||
| Price To Earning | 2.70 X | ||||
| Price To Book | 0.54 X | ||||
| Price To Sales | 27.82 X | ||||
| Revenue | 431.38 K | ||||
| EBITDA | (9.6 M) | ||||
| Cash And Equivalents | 4.22 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 3.28 M | ||||
| Debt To Equity | 0.23 % | ||||
| Book Value Per Share | 4.79 X | ||||
| Cash Flow From Operations | (7.72 M) | ||||
| Earnings Per Share | 0.30 X | ||||
| Total Asset | 20.64 M | ||||
| Retained Earnings | (68.16 M) | ||||
| Current Asset | 25.7 M | ||||
| Current Liabilities | 10.9 M | ||||
About Aptorum Group Performance
By examining Aptorum Group's fundamental ratios, stakeholders can obtain critical insights into Aptorum Group's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Aptorum Group is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.Things to note about Aptorum Group performance evaluation
Checking the ongoing alerts about Aptorum Group for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aptorum Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aptorum Group is way too risky over 90 days horizon | |
| Aptorum Group appears to be risky and price may revert if volatility continues | |
| Aptorum Group has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 431.38 K. Reported Net Loss for the year was (4.34 M) with profit before taxes, overhead, and interest of 81.85 K. | |
| Aptorum Group Ltd has about 4.22 M in cash with (7.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Aptorum Group has a frail financial position based on the latest SEC disclosures | |
| Roughly 24.0% of the company shares are held by company insiders |
- Analyzing Aptorum Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aptorum Group's stock is overvalued or undervalued compared to its peers.
- Examining Aptorum Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aptorum Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aptorum Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aptorum Group's stock. These opinions can provide insight into Aptorum Group's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptorum Group Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptorum Group. If investors know Aptorum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptorum Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aptorum Group is measured differently than its book value, which is the value of Aptorum that is recorded on the company's balance sheet. Investors also form their own opinion of Aptorum Group's value that differs from its market value or its book value, called intrinsic value, which is Aptorum Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptorum Group's market value can be influenced by many factors that don't directly affect Aptorum Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptorum Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptorum Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptorum Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.